title: Response to comment on Sarkar et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes care 2014;37:666-670.
authors.affiliation: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
authors.forename: Gayatri
authors.initials: G
authors.lastname: Sarkar
authors.affiliation: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
authors.forename: May
authors.initials: M
authors.lastname: Alattar
authors.affiliation: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
authors.forename: Rebecca J
authors.initials: RJ
authors.lastname: Brown
authors.affiliation: Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Quon
authors.affiliation: Diabetes Division, Internal Medicine Department, University of Massachusetts School of Medicine and UMass Memorial Health Care, Worcester, MA.
authors.forename: David M
authors.initials: DM
authors.lastname: Harlan
authors.affiliation: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD kristina.rother@nih.gov.
authors.forename: Kristina I
authors.initials: KI
authors.lastname: Rother
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D010455:Peptides / Q000008:administration & dosage*; D014688:Venoms / Q000008:administration & dosage*
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms